These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4755064)

  • 21. [Congenital absence of the fibrin-stabilizing factor. (Factor 13)].
    Ciepielewska D; Lopaciuk S
    Pediatr Pol; 1970 Jul; 45(7):829-32. PubMed ID: 5449789
    [No Abstract]   [Full Text] [Related]  

  • 22. Enzymatic method for the quantitative determination of factor. XIII. Application to a familial deficiency.
    Janssen CL; Masure R
    Pathol Eur; 1970; 5(3):315-30. PubMed ID: 5477027
    [No Abstract]   [Full Text] [Related]  

  • 23. [Some indices of the blood coagulation system and antithrombin activity in protracted forms of infectious hepatitis].
    Dorofeeva RP
    Vrach Delo; 1969 Oct; 10():102-4. PubMed ID: 5366766
    [No Abstract]   [Full Text] [Related]  

  • 24. [Disorder of the blood coagulation system in children with viral hepatitis (Botkin's disease) and hemorrhagic syndrome].
    Lavrova KV; Khabidulina LA; Kroshkina LM
    Pediatriia; 1974; 53(5):49-50. PubMed ID: 4848510
    [No Abstract]   [Full Text] [Related]  

  • 25. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 26. Deficiency of fibrin stabilizing factor (FSF) in kala-azar.
    Basu AK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1969 Apr; 17(2):35-6. PubMed ID: 5401878
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of Botkin's disease with heparin].
    Pateiuk VG; Kuznik BI; Kuz'min VG
    Klin Med (Mosk); 1973 Mar; 51(3):113-7. PubMed ID: 4755465
    [No Abstract]   [Full Text] [Related]  

  • 28. New families with hereditary hemorrhagic trait due to deficiency of fibrin stabilizing factor (F. 13).
    Egeberg O
    Thromb Diath Haemorrh; 1968 Dec; 20(3):534-41. PubMed ID: 5710470
    [No Abstract]   [Full Text] [Related]  

  • 29. [The significance of changes in the functional properties of blood platelets, factor XIII activity and fibrin clot quality in the pathogenesis of hemorrhagic diathesis secondary to experimental vitamin C deficiency].
    Sushkevich GN; Khnychev SS; Oĭvin VI
    Vopr Pitan; 1969; 28(5):23-7. PubMed ID: 5370913
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood coagulation factors during epidemic hepatitis in children].
    Seiler G; Gröpl H
    Arch Kinderheilkd; 1969 Jul; 179(2):164-71. PubMed ID: 5802842
    [No Abstract]   [Full Text] [Related]  

  • 31. [Severe viral hepatitis. Intravascular coagulation and fibrinolysis. Radioisotopic study of the life of platelets and fibrinogens].
    Dechavanne M; Bouletreau P; Petit P
    Presse Med (1893); 1971 Dec; 79(54):2485-6. PubMed ID: 5157899
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrin stabilizing factor (FSF)].
    Policlinico Prat; 1968 Jun; 75(23):751-5. PubMed ID: 5740614
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some problems of pathogenesis of hemorrhagic manifestations in typhoid fever].
    Bogolitsyn IuG
    Ter Arkh; 1969 May; 41(5):81-4. PubMed ID: 5309140
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological study of hemostasis during benign viral hepatitis].
    Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux H; Molinie C
    Med Chir Dig; 1975; 4(4):203-9. PubMed ID: 1207195
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnostics and therapy of hemolytic-hemorrhagic transfusion incidents].
    Brüster H
    Zentralbl Neurochir; 1972; 33(1):63-8. PubMed ID: 5072151
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
    Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coagulation factors during the development of common viral hepatitis].
    Thabaut A; Laverdant Ch; Durosoir JL; Voinesson A; Cristau F; Essioux H; Molinie Cl; Allard P; Roue R
    Ann Med Interne (Paris); 1975; 126(8-9):639-48. PubMed ID: 1217772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical laboratory characteristics of the severe form of hereditary fibrin-stabilizing factor (factor XIII) deficiency].
    Barkagan LZ; Arkhipov BF
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):54-8. PubMed ID: 7413627
    [No Abstract]   [Full Text] [Related]  

  • 39. [Factor XIII (fibrin stabilizing factor) in cutaneous epitheliomas].
    Argenziano G; Rossi A
    G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):69-72. PubMed ID: 5467616
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.